Detalles de la búsqueda
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; : 1-19, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861289
2.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; : 1-19, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682738
3.
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Anticancer Drugs
; 34(1): 178-186, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36539370
4.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358628
5.
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract
; 29(7): 1748-1753, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282554
6.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920559
7.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180954
8.
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Eur J Nucl Med Mol Imaging
; 49(3): 1063-1074, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486070
9.
Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient.
Anticancer Drugs
; 33(1): e724-e729, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261919
10.
Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.
Curr Oncol Rep
; 24(12): 1851-1862, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255605
11.
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients.
Int J Mol Sci
; 23(9)2022 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35563100
12.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
13.
Multiple systemic treatment options in a patient with malignant tenosynovial giant cell tumour.
Anticancer Drugs
; 31(1): 80-84, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31567307
14.
Cabozantinib-related cardiotoxicity: a prospective analysis in a real-world cohort of metastatic renal cell carcinoma patients.
Br J Clin Pharmacol
; 85(6): 1283-1289, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740760
15.
The Optimal Duration of Adjuvant Therapy for Stage III Colon Cancer: the European Perspective.
Curr Treat Options Oncol
; 20(1): 8, 2019 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30684093
16.
Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau".
Hum Vaccin Immunother
; 20(1): 2351669, 2024 Dec 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38757563
17.
Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review.
Front Oncol
; 14: 1338438, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601761
18.
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis.
Eur Urol Oncol
; 7(2): 179-188, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37574390
19.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer
; 22(2): 126-133.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932204
20.
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27.
Clin Genitourin Cancer
; 22(3): 102078, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38631104